Name: Pasithea Therapeutics Corp. (KTTA) Financial Statements
Creator: FinSpry

Pasithea Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Pasithea Therapeutics Corp. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.02	0.00
Cost of Revenue	0.00	0.00	0.11	0.02	0.00
Gross Profit	0.00	0.00	0.37	0.00	0.00
Operating Expenses
Research & Development	7.20	8.10	2.67	0.00	0.00
Selling, General & Administrative	7.05	7.88	9.92	4.51	0.06
Operating Expenses	14.25	15.98	12.59	4.51	0.06
Operating Income	-14.25	-15.98	-12.59	-4.51	-0.06
Other Income/Expense
Interest Income	0.42	0.42	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.08	0.06	1.85	2.33	0.00
Income
Income Before Tax	-13.90	-15.51	-11.73	-2.17	-0.06
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-13.90	-15.96	-13.94	-2.17	-0.06
Net Income - Continuous Operations	-13.90	-15.51	-11.73	-2.17	0.00
Net Income - Discontinued Operations	0.00	-0.45	-2.21	0.00	0.00
EBITDA	-13.60	-15.33	-12.58	-4.51	0.00
EBIT	-14.25	-15.98	-12.59	-4.51	-0.06
Depreciation & Amortization	0.65	0.65	0.01	0.00	0.00
Earnings Per Share
Basic EPS	-13.00	-13.00	-11.00	-4.00	-
Diluted EPS	-13.00	-13.00	-11.00	-4.00	-
Basic Shares Outstanding	1.10	1.23	1.26	0.52	0.37
Diluted Shares Outstanding	1.10	1.23	1.26	0.52	0.37